Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat
about
Methamphetamine effects on blood-brain barrier structure and functionMultiple sclerosis: molecular mechanisms and therapeutic opportunitiesProinflammatory treatment of astrocytes with lipopolysaccharide results in augmented Ca2+ signaling through increased expression of via phospholipase A2 (iPLA2)Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.Spatiotemporal correlations between blood-brain barrier permeability and apparent diffusion coefficient in a rat model of ischemic strokeMicroglial TNFα Induces COX2 and PGI2 Synthase Expression in Spinal Endothelial Cells during Neuropathic Pain.Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid.A role for cyclooxygenase-1 in beta-amyloid-induced neuroinflammation.Mmp-9, a potential target for cerebral ischemic treatment.Cyclooxygenase-1 and -2 differentially modulate lipopolysaccharide-induced blood-brain barrier disruption through matrix metalloproteinase activityAnti-Inflammatory Agents for Cancer Therapy.Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications.Cyclooxygenase-2 inhibitor blocks the production of West Nile virus-induced neuroinflammatory markers in astrocytes.Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.Matrix metalloproteinase-3 in odontoblastic cells derived from ips cells: unique proliferation response as odontoblastic cells derived from ES cellsBrain-reactive antibodies and disease.Interleukin-1β-induced autophagy-related gene 5 regulates proliferation of embryonic stem cell-derived odontoblastic cells.The TNF-α/NF-κB signaling pathway has a key role in methamphetamine-induced blood-brain barrier dysfunctionTempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory painCyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain.Indomethacin protects rats from neuronal damage induced by traumatic brain injury and suppresses hippocampal IL-1β release through the inhibition of Nogo-A expression.Effects of Etanercept against Transient Cerebral Ischemia in Diabetic Rats.Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke.Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor MicroenvironmentPersistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier.Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic strokeAging is associated with dimerization and inactivation of the brain-enriched tyrosine phosphatase STEP.Neurovascular unit in chronic pain.Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage.Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injuryInvolvement of ROS in BBB dysfunction.MMP-3 Deficiency Alleviates Endotoxin-Induced Acute Inflammation in the Posterior Eye Segment.Infection of pericytes in vitro by Japanese encephalitis virus disrupts the integrity of the endothelial barrier.Mmp-9 inhibition: a therapeutic strategy in ischemic stroke.Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology.The blood-brain barrier in neuroimmunology: Tales of separation and assimilation.Helicobacter pylori and neurological diseases: Married by the laws of inflammation.Effect of Early and Prophylactic Nonsteroidal Anti-Inflammatory Drugs on Flare Duration in Pediatric Acute-Onset Neuropsychiatric Syndrome: An Observational Study of Patients Followed by an Academic Community-Based Pediatric Acute-Onset NeuropsychiaThe Role of Matrix Metalloproteinase 3 and 9 in the Pathogenesis of Acute Neuroinflammation. Implications for Disease Modifying Therapy.
P2860
Q26825795-DB67A11D-4FC5-4EE0-9DE3-058CB76B910BQ27023735-5640173A-D4D0-43E7-868B-7F0CD541394FQ28575087-73FADC36-FE42-4189-B12C-2157854B5D4CQ30428613-FCDB01FE-6DB2-4D0C-93A2-E15EEC6BC444Q33492311-3FEF4839-3880-48C5-AA65-63AE958C4D53Q33588645-09CF9889-0AE9-4BDB-B9CA-89752CA90112Q33588687-37E599BD-E016-46C4-BD8D-486C550EA06CQ33588710-7EA1530C-652E-4A8B-A2EB-4944D49ACF9FQ33612510-FE33887A-884C-433A-8590-5AB4B8EC1D5CQ33638396-7D6C0533-ECD6-4B36-8F55-FFD856913839Q33744129-C2E14B30-C459-4781-B70C-ADA5B5595156Q34432388-BBEDC98A-94F9-4B99-9D85-C043CA4A3378Q34840113-440FCE9D-6D7A-4038-B0CF-73135C03A522Q35005089-10D846CC-42FC-44D5-BDFE-75DF70E23C63Q35073126-C3268F81-B199-43AA-BA66-74D227A2609FQ35458567-B3049ECA-CB24-49F4-8B75-05ED5F5FBD20Q35610047-8850A2E1-CCDA-493D-B14A-3066BE270D02Q35925469-BCC76629-28F8-4D7F-B627-009C425B4EDCQ35964989-CAE7F9C0-F0CF-4BBE-9E65-EDEDA3D35DADQ36067379-B1889ADC-C27D-46AD-A805-C63C20CA2646Q36156649-6B65C758-29C5-4B46-A226-C8BF658DAADCQ36343103-ED5B2D90-4DB6-4FE8-8595-CFA7CC346AA0Q36357707-EEF326A2-B34D-4786-A1C5-AB3BE9463C32Q36644315-411AAD64-6A07-4CC9-9830-D41CAD5144B0Q36658280-9B3FCA62-61EC-4131-866E-A4F0A05290F2Q36730363-0293FC20-945A-4ADB-978B-AE0C56FEDA8AQ36750801-299030F1-BCEE-4530-9347-694F1A54F216Q36827917-61A9766F-D3F3-424B-89EA-06C4F89E390AQ36942721-3CF86B6B-1177-4CB9-90D6-BC134D219493Q37152242-67861D9C-068E-48D2-A812-D92F86114331Q37393237-414E392A-31C9-4842-8599-23593A495FA7Q37400756-05A5B9D3-6D44-47F2-84E3-7F2EF5764BAEQ37465463-A4DD87F4-B028-4AD3-8972-B31B8FB1DC10Q37547516-6D8F6499-21D9-41D0-A0C3-A785E4888C5BQ37568882-FF8C8EA8-6C03-48E3-8F08-1588B641619FQ38126949-D801FE4C-5D04-4F65-B143-ABF84AEC217DQ38244770-64242C15-7416-417B-A824-F3B76D68B500Q38268664-F62157D3-6E22-48D0-99C2-F5A41E18BB49Q38684263-6E872271-41D1-43AF-BAD0-F7E43D2FA266Q39036823-BE2AB4CD-8BFB-4258-9F6F-2079409FAE7D
P2860
Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat
description
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im November 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/11/01)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/11/01)
@nl
наукова стаття, опублікована в листопаді 2007
@uk
مقالة علمية نشرت في نوفمبر 2007 حول موضوع: دماغ
@ar
name
Cyclooxygenase inhibition limi ...... crosis factor-alpha in the rat
@ast
Cyclooxygenase inhibition limi ...... crosis factor-alpha in the rat
@en
Cyclooxygenase inhibition limi ...... crosis factor-alpha in the rat
@nl
type
label
Cyclooxygenase inhibition limi ...... crosis factor-alpha in the rat
@ast
Cyclooxygenase inhibition limi ...... crosis factor-alpha in the rat
@en
Cyclooxygenase inhibition limi ...... crosis factor-alpha in the rat
@nl
prefLabel
Cyclooxygenase inhibition limi ...... crosis factor-alpha in the rat
@ast
Cyclooxygenase inhibition limi ...... crosis factor-alpha in the rat
@en
Cyclooxygenase inhibition limi ...... crosis factor-alpha in the rat
@nl
P2093
P356
P1476
Cyclooxygenase inhibition limi ...... crosis factor-alpha in the rat
@en
P2093
Bernd L. Fiebich
Eduardo Y. Estrada
Gary A. Rosenberg
Mark Grossetete
Rohit Sood
Saeid Taheri
P304
P356
10.1124/JPET.107.127035
P407
P577
2007-11-01T00:00:00Z